Thin Air Labs

Building a company is hard. Staying well while you do it? Even harder. Leah Sarich returns to Collisions YYC for a heartfelt, unfiltered conversation about the founder experience, the power of storytelling, and why Thin Air Labs puts humans first—always. Leah shares what she’s learned after five years in Alberta’s venture space, why community beats competition, and how her own podcast, The Founder Mindset, is giving entrepreneurs space to be seen, heard, and supported. We talk about authenticity, burnout, the future of funding, and why Calgary’s collaborative culture still sets us apart. This one’s all heart. Tune in now: https://lnkd.in/ej7Zj_6g

🚀 Syantra: Pioneering the Future of Cancer Detection It has been an incredible journey—and we have been heads down building! Over the past year, Syantra has achieved significant milestones in our mission to revolutionize cancer detection. 🔹 $4.9M Series A-1 Funding Secured: This investment propels the clinical validation and commercialization of our Onco-ID™ platform. 🔹 Strategic Partnership with Limmi: Collaborating with Limmi enhances our AI-driven, RNA-based liquid biopsy platform, advancing early cancer detection capabilities. 🔹 Leadership Expansion: We welcomed Rob Lozuk as CEO, bringing extensive experience in biotech commercialization. 🔹 Board Enrichment: Holly Smithson, a breast cancer survivor and STEM advocate, joined our Board of Directors, aligning personal experience with our mission. 🔹 Global Clinical Study Initiation: In partnership with Cornell University and the University of Calgary, we commenced a $2.4M DoD-funded study involving 2,000 participants to expand our early breast cancer detection research. As we advance, we're committed to sharing more about our technology, team, and the impact we're making. 👉 Follow our journey and stay updated on our progress. #Biotech #CancerDetection #Innovation #Syantra

This Wednesday! Don’t miss this session for founders, operators and finance leaders about optimizing your capital stack. Andrew Browne of Thin Air Labs and our own Spencer Gunning, CBV will share strategies to pursue the right mix of financing to fund your growth. Join us in person at McCarthy Tétrault, our lunch and location partner, or join online! Read more and register: https://lu.ma/rmg6zerg

🌎Calling all international companies! Are you planning to enter the North American market in the next 1-5 years? Are you looking to de-risk your launch? Look no further! Our North American Soft Landing Program will provide you with strategic insights to help you prepare for future planning. 📅 The two-week program runs from September 15-26, 2025, in Calgary and Edmonton, Canada. It offers international companies a soft landing entry point to the lucrative North American market. This opportunity comes with: ✅ Introduction to the life sciences and health tech network ✅Funding opportunities ✅Introductions into organizations and resources available in Alberta that support market entry. 💼Program features include clinical trials opportunities, research collaborations, and understanding pathways into the US market. This program delves into strategies for navigating recent trade policies with the US, which includes updates on USMCA. 💡If you’re an international company in diagnostics, medical devices, oncology, biomanufacturing, or digital health aiming to set up a subsidiary in North America, this program is designed for you! Deadline to apply is June 2, 2025. 👇Click below to learn more! https://zurl.co/XFwrZ #LifeSciences #HealthTech #BioTech #Innovation #International #Growth #BusinessDevelopment #Canada